USFDA inspection of Biocon's drug substance unit at Bengaluru complete

The week-long audit concluded without any observations and no Form 483 was issued, it added.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2QSvyYa
via IFTTT